EDITORIAL SECTION
-
STRATEGY
Strategic Positioning for M&A
The biotechnology sector is characterised by a constant influx of small highly specialised companies
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solutions help reduce contamination risk and lower manual handling
-
CLINICAL TRIALS
Virtual Clinical Trials
Virtual digital and decentralized are all descriptions of the novel ways that using technology changes
-
Bio Pharma
Biosimilars and Biobetters
Biosimilars are biologic medical products that are essentially identical to an original product manufactured
-
MANUFACTURING
Transformative Convergence of AI in Pharmaceutical Manufacturing
The pharmaceutical manufacturing industry is on the cusp of a revolutionary transformation driven by
-
Information Technology
Transformative Impact of Artificial Intelligence on Clinical Trials
Artificial Intelligence AI has rapidly evolved from a futuristic concept to a transformative tool across various industries
-
EXPERT Talk
Pharma's Medical Affairs Bridge: From Field Insights and Stakeholder Needs to Global Scientific Strategy
Medical Affairs has evolved from being primarily a supportive and educational function to becoming a strong strategic partner earlier on Through ongoi...
Advisory Board
.webp "Juris Hmelnickis")
.webp "Eiman Shafa")
KNOWLEDGE BANK
-
Articles
Digital Transformation in Pharmaceutical Supply Chain Management
For decades the American pharmaceutical supply chain was judged on two measures cost and compliance Product moved from manufacturer to wholesaler to dispenser through a chain of largely disconnected systems and visibility often ended at the loading dock That model has reached its limits The pandemic extended drug shortages sterile injectable disruptions and new federal traceability mandates have e...
-
Techno Trends
Lilly’s Jaypirca Gains FDA Approval for First-Line CLL/SLL Treatment
Eli Lilly and Company has received approval from the US Food and Drug Administration FDA for an additional indication for Jaypirca pirtobrutinib in adults with previously untreated chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL without a known p deletion The approval enables Jaypirca to be used as a firstline treatment
-
Projects
Genentech Begins US$750 Million Expansion of Oregon Manufacturing Facility
Genentech a member of the Roche Group has started construction on a US million expansion of its manufacturing facility in Hillsboro Oregon The squarefoot project will double the existing sites footprint and increase US production capacity for advanced drug delivery devices
-
Research Insights
Salivary and serum levels of NT-proBNP, troponin, and high-sensitivity C-reactive protein in patients with heart failure
Saliva has been proposed as a noninvasive biological matrix for cardiovascular biomarker assessment However evidence regarding its agreement with bloodbased measurements in patients with heart failure remains inconsistent
-
White Papers
Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact
For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys complexity
TOP ARTICLES
-
1
Bioprocessing & Bioproduction In-Depth Focus 2025
Kate Williamson
The bioprocessing and bioproduction sector of 2025 experiences fundamental changes through continuous processing and digitalization and sustainability and advanced therapeutic advancements. Advances i...
-
2
Beyond the Chiral Blind Spot: Agentic AI and the Future of Stereochemistry-Aware Drug Discovery
Sivakumar Thanikachalam
Valliappan Kannappan
Artificial intelligence is transforming drug discovery, yet stereochemistry remains a major blind spot. This article explores how Agentic AI could integrate stereochemical reasoning across molecular d...
-
3
How Biosimilars Are Changing Competition in the U.S. Drug Market
Lakshmi
Biosimilars have saved the U.S. healthcare system $81.6 billion since 2015, yet their real impact is strategic rather than purely financial. This article examines how biosimilars are reshaping competi...
-
4
Green Chemistry in Pharma: Sustainable Drug Manufacturing
Kate Williamson
Green chemistry in pharmaceutical industry is converting the customary operations to models of sails in drug manufacturing. The green pharmaceutical industry minimizes waste and carbon footprint by ta...
-
5
Challenges and Compliance in Pharma HCP Communication
Kate Williamson
The communication between Pharma HCP is necessary to provide clinical insights and guarantee pharmaceutical compliance. This article will reveal the ethical issues, regulatory policies, and ethical pr...
press releasesRead more...
Repligen completes acquisition of BioLife Solutions
Repligen Corporation NASDAQ RGEN Repligen or the Company a life sciences company focused on bioprocessing technology leadership today announced it has completed the previously announced
Electron Bio Launches FAST GMP™ Modular Cleanroom Platform and FAST QMS™
Electron Bio today launched FAST GMP its patentpending modular cleanroom platform for cGMP manufacturing together with FAST QMS and CMC services Electron Bio conceived and designed
ORIC® Pharmaceuticals Announces Agreement with Cancer Research UK to Advance a Potential First-in-Class CIP2A-Targeted Therapy Into Clinical Development
ORIC Pharmaceuticals Inc Nasdaq ORIC a clinical stage oncology company focused on developing and commercializing treatments that address mechanisms of therapeutic resistance
Pacira Announces Exclusive Agreement with Molteni Farmaceutici to Commercialize EXPAREL® in the European Union and United Kingdom
Pacira BioSciences Inc NASDAQ PCRX the industry leader in its commitment to deliver innovative nonopioid pain therapies to transform the lives of patients today announced a strategic partnership with Molteni
Events Read more...
12 - 14
Oct 2026Pharmaceutics 2026
Village Hotel Changi, Singapor...
12 - 13
Oct 20262nd International Conference on Drug Discovery
Village Hotel Changi, Singapor...
21 - 23
Oct 2026Drug Formulation & Drug Delivery 2026
Paris, France
21 - 22
Oct 2026Advance Clinical Trials and Research 2026
Paris, France
22 - 23
Oct 2026PDA Aseptic Symposium 2026
Congress Square Nakanoshima, O...
26 - 28
Oct 2026ACHEMA Middle East 2026
RICEC, Riyadh, KSA, Saudi Arab...
26 - 28
Oct 2026World Orphan Drug Congress
RAI, Amsterdam, Netherlands
27 - 28
Oct 2026PM& AC 2026
Novotel Hyderabad Convention C...
LATEST NEWSRead more...
PacBio and TychoBio Collaborate to Train AI Models for Rare Disease RNA Therapeutics
PacBio and TychoBio have announced a collaboration to generate fulllength RNA data for training artificial intelligence AI models that support the design of RNA therapies for rare diseases
Relay Network and Claritas Rx Announce Strategic Partnership to Advance Patient Engagement for Specialty and Rare Disease Programmes
Relay Network and Claritas Rx have announced a strategic partnership to help life sciences companies improve patient access support and treatment adherence across specialty and rare disease programmes
Psyence BioMed Partners with Benuvia to Establish U.S. Manufacturing of Pharmaceutical-Grade Ibogaine
Psyence Biomedical Ltd Nasdaq PBM through its wholly owned Texas subsidiary Texas Ibogaine Research Corporation TIRC has entered into a manufacturing services agreement with Benuvia Operations
Italfarmaco and VeriSIM Life Partner to Develop HDAC-Targeted Therapies for Neuromuscular and Rare Diseases
Italfarmaco SpA and VeriSIM Life have entered into a strategic collaboration to discover and develop novel histone deacetylase HDACtargeted therapies for neuromuscular fibrotic and rare diseases
Bayer to invest $2.2 billion in new US pharmaceutical manufacturing site
Bayer plans to invest billion in a new pharmaceutical manufacturing site in New Albany Ohio in the United States The project is part of the companys longterm growth strategy and will support its focus on innovation and patient access in the US pharmaceutical market
Italfarmaco and JCR Pharmaceuticals sign exclusive licence agreement for Hunter syndrome therapy
Italfarmaco and JCR Pharmaceuticals have entered into an exclusive licence agreement to develop and potentially commercialise JR in the United States Europe and Latin America subject to regulatory approval
